Valuation : Olympus Corporation

Market Cap 2,284B 14.28B 12.3B 11.54B 10.53B 19.84B 1,365B 19.9B 137B 53.4B 689B 53.6B 52.44B P/E 2027 *
21.9x
P/E 2028 * 18.9x
Enterprise Value 2,366B 14.79B 12.74B 11.95B 10.91B 20.55B 1,413B 20.61B 142B 55.31B 713B 55.52B 54.31B EV / Sales 2027 *
2.19x
EV / Sales 2028 * 2.1x
Free-Float
94.58%
Yield 2027 *
1.43%
Yield 2028 * 1.5%
1 day+0.35%
1 week-0.90%
Current month+18.08%
1 month+19.26%
3 months+17.98%
6 months+40.64%
Current year+8.29%
1 week 2,100
Extreme 2100
2,206.5
1 month 1,761
Extreme 1761
2,210.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%-0.90%+23.79%+13.79% 14.28B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
Average -0.75%-1.34%+15.33%+13.81% 81.55B
Weighted average by Cap. -0.45%-1.49%+8.49%+9.38%

Financials

2027 *2028 *
Net sales 1,079B 6.75B 5.81B 5.45B 4.98B 9.37B 645B 9.4B 64.67B 25.23B 325B 25.33B 24.78B 1,117B 6.98B 6.02B 5.64B 5.15B 9.7B 667B 9.73B 66.92B 26.11B 337B 26.21B 25.64B
Net income 105B 656M 565M 530M 484M 912M 62.71B 914M 6.29B 2.45B 31.65B 2.46B 2.41B 122B 761M 655M 615M 561M 1.06B 72.7B 1.06B 7.29B 2.84B 36.7B 2.86B 2.79B
Net Debt 81.71B 511M 440M 413M 377M 710M 48.82B 712M 4.9B 1.91B 24.64B 1.92B 1.88B 64.09B 401M 345M 324M 295M 557M 38.29B 558M 3.84B 1.5B 19.33B 1.5B 1.47B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-28 ¥2,149.00 +0.35% 5,347,300
26-08-27 ¥2,141.50 +0.40% 5,568,100
26-08-26 ¥2,133.00 -1.52% 3,323,200
26-08-25 ¥2,166.00 +0.28% 3,523,400
26-08-24 ¥2,160.00 -0.39% 3,096,700
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,149.00JPY
Average target price
2,157.69JPY
Spread / Average Target
+0.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock